bordetella pertussis antigens
PolandDrugs containing this active substance
-
The vaccine is used to prevent diphtheria, tetanus, and pertussis (whooping cough). It helps the body develop its own immunity to these three diseases.
Form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid No input provided tetanus toxoid No input provided bordetella pertussis antigens No input provided ATC: J07AJ52
Manufacturer: GlaxoSmithKline Biologicals S.A.
-
The vaccine is used to prevent diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio). It helps the body develop immunity to these four diseases.
Form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid > or equal to 2 IU (2.5 Lf) aluminum phosphate 0.2 mg Al 3+ inactivated poliovirus type 1 40 units of antigen D inactivated poliovirus type 2 8 units of antigen D inactivated poliovirus type 3 32 units of antigen D tetanus toxoid > or equal 20 IU (5 Lf) aluminum hydroxide hydrate 0.3 mg Al 3+ bordetella pertussis antigens 8 mcg + 8 mcg + 2.5 mcg ATC: J07CA02
Manufacturer: GlaxoSmithKline Biologicals S.A.
-
The vaccine is used to prevent diphtheria, tetanus, pertussis (whooping cough), poliomyelitis (polio), and infections caused by Haemophilus influenzae type b (Hib) in children.
Form: powder and suspension for preparation of injection suspension
Active substance Dosage diphtheria toxoid No input provided tetanus toxoid No input provided bordetella pertussis antigens No input provided inactivated poliovirus types 1, 2 and 3 No input provided haemophilus b polysaccharide conjugated with tetanus toxoid No input provided ATC: J07CA06
Manufacturer: GlaxoSmithKline Biologicals S.A.
-
The vaccine helps protect children from 6 weeks of age against diphtheria, tetanus, pertussis, poliomyelitis, and invasive infections caused by Haemophilus influenzae type b (such as meningitis or septicaemia).
Form: powder and suspension for preparation of injection suspension
Active substance Dosage inactivated poliovirus type 1 40 units of antigen D inactivated poliovirus type 2 8 units of antigen D inactivated poliovirus type 3 32 units of antigen D haemophilus influenzae type b conjugated polysaccharide-tetanus toxoid conjugate 10 mcg diphtheria toxoid not less than 30 IU tetanus toxoid not less than 40 IU bordetella pertussis antigens 25 mcg + 25 mcg ATC: J07CA02
Manufacturer: Sanofi Winthrop Industrie
-
The vaccine helps protect the child against diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio).
Form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid minimum 30 IU tetanus toxoid minimum 40 IU bordetella pertussis antigens 25 micrograms poliovirus type 1 mahoney strain inactivated 40 units of antigen D poliovirus type 2 mef-1 strain inactivated 8 units of antigen D poliovirus type 3 sabin strain inactivated 32 units of antigen D ATC: J07CA02
Manufacturer: Sanofi Winthrop Industry Sanofi Winthrop Industry Sanofi-Aventis Ltd.